The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Delivery Nanoparticles Formulation Market Research Report 2024
Synopsis
Drug delivery nanoparticle formulations generally refer to drug delivery systems designed and prepared through nanotechnology to improve drug delivery efficiency, reduce drug dosage, reduce side effects, and achieve more precise therapeutic effects. This involves using nanomaterials as drug carriers and modulating the properties of drug delivery through specific formulations and preparation processes.
The global Drug Delivery Nanoparticles Formulation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Drug Delivery Nanoparticles Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Delivery Nanoparticles Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Delivery Nanoparticles Formulation in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Delivery Nanoparticles Formulation include CD Bioarticles, Evonik Health Care, Sanner, Lubrizol Life Science Health (LLS Health), Kindeva Drug Delivery, Beijing TheraXyte Biotechnology, Altasciences, Stevanato Group and RiboBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Nanoparticles Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Nanoparticles Formulation.
Report Scope
The Drug Delivery Nanoparticles Formulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Nanoparticles Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Nanoparticles Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Bioarticles
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
Segment by Type
Oral Preparation
Injectable Preparations
Skin Preparations
Others
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Nanoparticles Formulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug delivery nanoparticle formulations generally refer to drug delivery systems designed and prepared through nanotechnology to improve drug delivery efficiency, reduce drug dosage, reduce side effects, and achieve more precise therapeutic effects. This involves using nanomaterials as drug carriers and modulating the properties of drug delivery through specific formulations and preparation processes.
The global Drug Delivery Nanoparticles Formulation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Drug Delivery Nanoparticles Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Delivery Nanoparticles Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Delivery Nanoparticles Formulation in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Delivery Nanoparticles Formulation include CD Bioarticles, Evonik Health Care, Sanner, Lubrizol Life Science Health (LLS Health), Kindeva Drug Delivery, Beijing TheraXyte Biotechnology, Altasciences, Stevanato Group and RiboBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Nanoparticles Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Nanoparticles Formulation.
Report Scope
The Drug Delivery Nanoparticles Formulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Nanoparticles Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Nanoparticles Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Bioarticles
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
Segment by Type
Oral Preparation
Injectable Preparations
Skin Preparations
Others
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Nanoparticles Formulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Preparation
1.2.3 Injectable Preparations
1.2.4 Skin Preparations
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Delivery Nanoparticles Formulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Nanoparticles Formulation Market Perspective (2019-2030)
2.2 Drug Delivery Nanoparticles Formulation Growth Trends by Region
2.2.1 Global Drug Delivery Nanoparticles Formulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery Nanoparticles Formulation Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery Nanoparticles Formulation Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery Nanoparticles Formulation Market Dynamics
2.3.1 Drug Delivery Nanoparticles Formulation Industry Trends
2.3.2 Drug Delivery Nanoparticles Formulation Market Drivers
2.3.3 Drug Delivery Nanoparticles Formulation Market Challenges
2.3.4 Drug Delivery Nanoparticles Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue
3.1.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery Nanoparticles Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Nanoparticles Formulation Revenue
3.4 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio
3.4.1 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Nanoparticles Formulation Revenue in 2023
3.5 Drug Delivery Nanoparticles Formulation Key Players Head office and Area Served
3.6 Key Players Drug Delivery Nanoparticles Formulation Product Solution and Service
3.7 Date of Enter into Drug Delivery Nanoparticles Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Nanoparticles Formulation Breakdown Data by Type
4.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2025-2030)
5 Drug Delivery Nanoparticles Formulation Breakdown Data by Application
5.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery Nanoparticles Formulation Market Size (2019-2030)
6.2 North America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2019-2024)
6.4 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Nanoparticles Formulation Market Size (2019-2030)
7.2 Europe Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2019-2024)
7.4 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Nanoparticles Formulation Market Size (2019-2030)
9.2 Latin America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Bioarticles
11.1.1 CD Bioarticles Company Detail
11.1.2 CD Bioarticles Business Overview
11.1.3 CD Bioarticles Drug Delivery Nanoparticles Formulation Introduction
11.1.4 CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.1.5 CD Bioarticles Recent Development
11.2 Evonik Health Care
11.2.1 Evonik Health Care Company Detail
11.2.2 Evonik Health Care Business Overview
11.2.3 Evonik Health Care Drug Delivery Nanoparticles Formulation Introduction
11.2.4 Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.2.5 Evonik Health Care Recent Development
11.3 Sanner
11.3.1 Sanner Company Detail
11.3.2 Sanner Business Overview
11.3.3 Sanner Drug Delivery Nanoparticles Formulation Introduction
11.3.4 Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.3.5 Sanner Recent Development
11.4 Lubrizol Life Science Health (LLS Health)
11.4.1 Lubrizol Life Science Health (LLS Health) Company Detail
11.4.2 Lubrizol Life Science Health (LLS Health) Business Overview
11.4.3 Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Introduction
11.4.4 Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.4.5 Lubrizol Life Science Health (LLS Health) Recent Development
11.5 Kindeva Drug Delivery
11.5.1 Kindeva Drug Delivery Company Detail
11.5.2 Kindeva Drug Delivery Business Overview
11.5.3 Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Introduction
11.5.4 Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.5.5 Kindeva Drug Delivery Recent Development
11.6 Beijing TheraXyte Biotechnology
11.6.1 Beijing TheraXyte Biotechnology Company Detail
11.6.2 Beijing TheraXyte Biotechnology Business Overview
11.6.3 Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Introduction
11.6.4 Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.6.5 Beijing TheraXyte Biotechnology Recent Development
11.7 Altasciences
11.7.1 Altasciences Company Detail
11.7.2 Altasciences Business Overview
11.7.3 Altasciences Drug Delivery Nanoparticles Formulation Introduction
11.7.4 Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.7.5 Altasciences Recent Development
11.8 Stevanato Group
11.8.1 Stevanato Group Company Detail
11.8.2 Stevanato Group Business Overview
11.8.3 Stevanato Group Drug Delivery Nanoparticles Formulation Introduction
11.8.4 Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.8.5 Stevanato Group Recent Development
11.9 RiboBio
11.9.1 RiboBio Company Detail
11.9.2 RiboBio Business Overview
11.9.3 RiboBio Drug Delivery Nanoparticles Formulation Introduction
11.9.4 RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.9.5 RiboBio Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Drug Delivery Nanoparticles Formulation Introduction
11.10.4 Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Introduction
11.11.4 Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Catalent
11.12.1 Catalent Company Detail
11.12.2 Catalent Business Overview
11.12.3 Catalent Drug Delivery Nanoparticles Formulation Introduction
11.12.4 Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.12.5 Catalent Recent Development
11.13 Asymchem
11.13.1 Asymchem Company Detail
11.13.2 Asymchem Business Overview
11.13.3 Asymchem Drug Delivery Nanoparticles Formulation Introduction
11.13.4 Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.13.5 Asymchem Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Detail
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Drug Delivery Nanoparticles Formulation Introduction
11.14.4 Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2019-2024)
11.14.5 Samsung Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
